Q2 2023 · 13F-HR
DEERFIELD MANAGEMENT COMPANY, L.P.holdings as filed
Filed 2023-08-14 · accession 0000950159-23-000249
$4.68B
Reported value
101
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $843.0M | 18.0% | 19,991,024 | Common | SOLE |
| 377322AB8 | GKOS 2.75 06/15/27 | GLAUKOS CORP | $412.7M | 8.81% | 271,452,000 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $176.7M | 3.77% | 17,703,484 | Common | SOLE |
| 023436108 | AMED | AMEDISYS INC | $164.0M | 3.50% | 1,794,000 | Common | SOLE |
| 632307AB0 | NTRA 2.25 05/01/27 | NATERA INC | $146.9M | 3.14% | 101,042,000 | Common | SOLE |
| 00653Q102 | AHCO | ADAPTHEALTH CORP | $135.0M | 2.88% | 11,094,914 | Common | SOLE |
| 462222AD2 | IONS 0 04/01/26 | IONIS PHARMACEUTICALS INC | $121.0M | 2.58% | 127,800,000 | Common | SOLE |
| 873379AA9 | — | TABULA RASA HEALTHCARE INC | $120.0M | 2.56% | 144,516,000 | Common | SOLE |
| 112463AC8 | BKD 2 10/15/26 | BROOKDALE SR LIVING INC | $114.8M | 2.45% | 145,955,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $114.1M | 2.44% | 1,209,714 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $110.1M | 2.35% | 8,192,000 | Common | SOLE |
| 00437EAB8 | — | ACCOLADE INC | $102.1M | 2.18% | 122,598,000 | Common | SOLE |
| 457669AA7 | — | INSMED INC | $98.2M | 2.10% | 103,200,000 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $94.4M | 2.02% | 6,707,026 | Common | SOLE |
| 45845PAC2 | — | INTERCEPT PHARMACEUTICALS IN | $94.0M | 2.01% | 98,354,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $91.0M | 1.94% | 1,349,000 | Common | SOLE |
| 690732102 | ACH | OWENS & MINOR INC NEW | $90.3M | 1.93% | 4,745,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $79.8M | 1.70% | 3,031,938 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $74.2M | 1.58% | 11,077,927 | Common | SOLE |
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $63.9M | 1.36% | 89,036,000 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $57.2M | 1.22% | 3,329,231 | Common | SOLE |
| 29332G102 | EHABUSD | ENHABIT INC | $55.3M | 1.18% | 4,809,803 | Common | SOLE |
| 63009RAD1 | — | NANOSTRING TECHNOLOGIES INC | $54.8M | 1.17% | 70,204,000 | Common | SOLE |
| 112463104 | BKD | BROOKDALE SR LIVING INC | $53.5M | 1.14% | 12,679,651 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $53.3M | 1.14% | 2,268,628 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $53.0M | 1.13% | 16,941,357 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $49.3M | 1.05% | 15,861,090 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $46.9M | 1.00% | 1,751,496 | Common | SOLE |
| 539183AA1 | TDOC 0.875 06/01/25 | LIVONGO HEALTH INC | $45.2M | 0.96% | 50,000,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $44.9M | 0.96% | 1,253,999 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $41.4M | 0.88% | 1,579,349 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $39.9M | 0.85% | 3,366,345 | Common | SOLE |
| 82710M100 | SILKUSD | SILK RD MED INC | $36.8M | 0.79% | 1,132,229 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $34.3M | 0.73% | 3,238,000 | Common | SOLE |
| 69366JAD3 | PTCT 1.5 09/15/26 | PTC THERAPEUTICS INC | $33.0M | 0.70% | 32,000,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $30.5M | 0.65% | 3,933,137 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $30.2M | 0.64% | 2,340,118 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $30.1M | 0.64% | 2,535,723 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $28.7M | 0.61% | 3,059,000 | Common | SOLE |
| 42225TAB3 | — | HEALTH CATALYST INC | $28.6M | 0.61% | 30,000,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $28.5M | 0.61% | 313,289 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $26.1M | 0.56% | 627,813 | Common | SOLE |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS IN | $23.0M | 0.49% | 2,077,893 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $22.7M | 0.48% | 1,050,198 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $22.0M | 0.47% | 870,000 | Common | SOLE |
| 98422LAA5 | — | XERIS BIOPHARMA HOLDINGS INC | $21.4M | 0.46% | 18,000,000 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $21.4M | 0.46% | 1,189,648 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $20.2M | 0.43% | 617,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $19.3M | 0.41% | 2,052,010 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $19.1M | 0.41% | 430,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $18.2M | 0.39% | 1,125,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $17.6M | 0.37% | 594,989 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $16.6M | 0.35% | 1,898,743 | Common | SOLE |
| 23312M106 | — | DA32 LIFE SCNCE TEC ACQSTN C | $16.4M | 0.35% | 1,600,000 | Common | SOLE |
| 46185LAB9 | — | INVITAE CORP | $15.3M | 0.33% | 17,211,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $15.2M | 0.32% | 1,269,992 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $14.3M | 0.30% | 837,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $14.0M | 0.30% | 1,064,285 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $13.9M | 0.30% | 658,546 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $13.7M | 0.29% | 1,354,974 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $13.6M | 0.29% | 650,000 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $13.2M | 0.28% | 2,823,000 | Common | SOLE |
| 88369M101 | — | THESEUS PHARMACEUTICALS INC | $13.1M | 0.28% | 1,400,352 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $13.0M | 0.28% | 885,314 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $12.5M | 0.27% | 613,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $11.7M | 0.25% | 650,000 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $11.4M | 0.24% | 1,538,461 | Common | SOLE |
| 05465P101 | AXNX* | AXONICS INC | $11.4M | 0.24% | 225,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $10.6M | 0.23% | 1,842,000 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $10.5M | 0.22% | 5,854,860 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $9.5M | 0.20% | 2,885,400 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $9.4M | 0.20% | 656,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $9.3M | 0.20% | 1,322,000 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $9.1M | 0.19% | 1,800,000 | Common | SOLE |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $7.5M | 0.16% | 1,253,895 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $6.3M | 0.14% | 1,055,192 | Common | SOLE |
| 64049MAA8 | — | NEOGENOMICS INC | $6.1M | 0.13% | 6,500,000 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $5.5M | 0.12% | 777,525 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $5.4M | 0.11% | 6,450,871 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $3.6M | 0.08% | 455,262 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $3.5M | 0.07% | 869,565 | Common | SOLE |
| G76279119 | — | ROIVANT SCIENCES LTD | $2.5M | 0.05% | 1,000,000 | Common | SOLE |
| 005111109 | AFIB | ACUTUS MED INC | $2.4M | 0.05% | 2,660,808 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $2.1M | 0.04% | 1,381,416 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $2.1M | 0.04% | 583,913 | Common | SOLE |
| 68236X100 | TOI | THE ONCOLOGY INSTITUTE INC | $1.8M | 0.04% | 3,360,052 | Common | SOLE |
| 68570P200 | — | ORCHARD THERAPEUTICS PLC | $1.6M | 0.04% | 316,169 | Common | SOLE |
| 74765K105 | QSI | QUANTUM SI INC | $1.4M | 0.03% | 797,500 | Common | SOLE |
| 38942Q202 | CALC | CALCIMEDICA INC | $1.1M | 0.02% | 265,657 | Common | SOLE |
| 14171W111 | — | CAREMAX INC | $259,392 | 0.01% | 672,000 | Common | SOLE |
| 58406B103 | — | MEDAVAIL HOLDINGS INC | $205,057 | 0.00% | 836,626 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $193,925 | 0.00% | 92,787 | Common | SOLE |
| 124155110 | BFLYW | BUTTERFLY NETWORK INC | $172,700 | 0.00% | 733,333 | Common | SOLE |
| 74765K113 | QSIAW | QUANTUM SI INC | $76,700 | 0.00% | 333,333 | Common | SOLE |
| 68236X118 | TOIIW | THE ONCOLOGY INSTITUTE INC | $34,875 | 0.00% | 1,250,000 | Common | SOLE |
| 83444K113 | — | SOMALOGIC INC | $30,000 | 0.00% | 120,000 | Common | SOLE |
| 82621J204 | S0Z0 | SIENTRA INC | $29,300 | 0.00% | 10,000 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $27,567 | 0.00% | 166,666 | Common | SOLE |
| 58507N113 | — | MEDTECH ACQUISITION CORP | $13,967 | 0.00% | 333,333 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $9,200 | 0.00% | 166,666 | Common | SOLE |
| 58507N204 | — | MEDTECH ACQUISITION CORP | $10 | 0.00% | 1 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.